(Q53957913)

22 May 2018

title

Granulocyte elastase-alpha 1-antiproteinase complex in cystic fibrosis: sensitive plasma assay for monitoring pulmonary infections. (English)

1 reference

22 May 2018

0 references

Hollsing AE

1

1 reference

22 May 2018

Lantz B

2

1 reference

22 May 2018

Bergström K

3

1 reference

22 May 2018

Malmborg AS

4

1 reference

22 May 2018

Strandvik B

5

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 August 1987

1 reference

22 May 2018

The Journal of Pediatrics

published in

1 reference

22 May 2018

volume

111

1 reference

22 May 2018

page(s)

206-211

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

Cystic Fibrosis—A Challenging Long-Term Chronic Disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Antibiotic use in cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Management of acute pulmonary exacerbations in cystic fibrosis: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Serum studies of leucocyte elastase in acute and chronic lung diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

A revised system for antibiotic sensitivity testing. The Swedish Reference Group for Antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Respiratory studies in children. IX. Relationships between mechanical properties of the lungs, lung volumes and ventilatory capacity in healthy children 7-15 years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2887%2980068-9

10.1016/S0022-3476(87)80068-9

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

3497250

1 reference

22 May 2018